nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime
|
Clemmons, Amber B. |
|
2018 |
24 |
4 |
p. 820-826 |
artikel |
2 |
Acute Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes
|
Koh, Kyung-Nam |
|
2018 |
24 |
4 |
p. 758-764 |
artikel |
3 |
Adverse Prognostic Factors for Morbidity and Mortality During Peripheral Blood Stem Cell Mobilization in Patients with Light Chain Amyloidosis
|
Yeh, Jason C. |
|
2018 |
24 |
4 |
p. 815-819 |
artikel |
4 |
Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
|
Wang, Jing |
|
2018 |
24 |
4 |
p. 741-750 |
artikel |
5 |
ASBMT and CBMTG Release Choosing Wisely BMT Recommendations
|
|
|
2018 |
24 |
4 |
p. 880-881 |
artikel |
6 |
BMT CTN Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling: Summary and Recommendations from the Organizing Committee
|
Holstein, Sarah A. |
|
2018 |
24 |
4 |
p. 641-648 |
artikel |
7 |
Burnout, Moral Distress, Work–Life Balance, and Career Satisfaction among Hematopoietic Cell Transplantation Professionals
|
Neumann, Joyce L. |
|
2018 |
24 |
4 |
p. 849-860 |
artikel |
8 |
Community Risk Score for Evaluating Health Care Disparities in Hematopoietic Cell Transplantation
|
Hong, Sanghee |
|
2018 |
24 |
4 |
p. 877-879 |
artikel |
9 |
Comparable Outcomes after HLA-Matched Sibling and Alternative Donor Hematopoietic Cell Transplantation for Children with Fanconi Anemia and Severe Aplastic Anemia
|
Ebens, Christen L. |
|
2018 |
24 |
4 |
p. 765-771 |
artikel |
10 |
Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission
|
Chen, Jia |
|
2018 |
24 |
4 |
p. 779-788 |
artikel |
11 |
Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation
|
Seo, Sachiko |
|
2018 |
24 |
4 |
p. 678-686 |
artikel |
12 |
Editorial Board
|
|
|
2018 |
24 |
4 |
p. A8 |
artikel |
13 |
Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia
|
Arima, Nobuyoshi |
|
2018 |
24 |
4 |
p. 717-725 |
artikel |
14 |
Identifying the Best Haploidentical Donor: Are We There?
|
Bacigalupo, Andrea |
|
2018 |
24 |
4 |
p. 638-640 |
artikel |
15 |
Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation
|
Yamamoto, Chihiro |
|
2018 |
24 |
4 |
p. 708-716 |
artikel |
16 |
Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients
|
Camargo, Jose F. |
|
2018 |
24 |
4 |
p. 806-814 |
artikel |
17 |
Impact of Dose-Adjusted Melphalan in Obese Patients Undergoing Autologous Stem Cell Transplantation
|
Shultes, Kendall C. |
|
2018 |
24 |
4 |
p. 687-693 |
artikel |
18 |
Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis
|
William, Basem M. |
|
2018 |
24 |
4 |
p. 827-831 |
artikel |
19 |
Increased Coexpression of PD-1, TIGIT, and KLRG-1 on Tumor-Reactive CD8+ T Cells During Relapse after Allogeneic Stem Cell Transplantation
|
Hutten, Tim J.A. |
|
2018 |
24 |
4 |
p. 666-677 |
artikel |
20 |
In the Era of BCR-ABL1 Inhibitors, Are We Closing the Survival Gap Between Allogeneic Hematopoietic Cell Transplantation and Chemotherapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in First Complete Remission?
|
Wieduwilt, Matthew J. |
|
2018 |
24 |
4 |
p. 637-638 |
artikel |
21 |
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
|
Kebriaei, Partow |
|
2018 |
24 |
4 |
p. 726-733 |
artikel |
22 |
Intravenous Busulfan Compared with Treosulfan-Based Conditioning for Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of European Society for Blood and Marrow Transplantation
|
Shimoni, Avichai |
|
2018 |
24 |
4 |
p. 751-757 |
artikel |
23 |
Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults
|
Sung, Anthony D. |
|
2018 |
24 |
4 |
p. 734-740 |
artikel |
24 |
Long-Term Safety of Short-Term Administration of Filgrastim (rhG-CSF) and Leukophresis Procedure in Healthy Children: Application of Peripheral Blood Stem Cell Collection in Pediatric Donors
|
Behfar, Maryam |
|
2018 |
24 |
4 |
p. 866-870 |
artikel |
25 |
Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Pediatric Disease Working Party
|
Paviglianiti, Annalisa |
|
2018 |
24 |
4 |
p. 799-805 |
artikel |
26 |
Masthead (Purpose and Scope)
|
|
|
2018 |
24 |
4 |
p. A6 |
artikel |
27 |
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study
|
Samaras, Panagiotis |
|
2018 |
24 |
4 |
p. 694-699 |
artikel |
28 |
Officers and Directors of ASBMT
|
|
|
2018 |
24 |
4 |
p. A10 |
artikel |
29 |
Prognostic Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in Adults with Chronic Myelomonocytic Leukemia: A Nationwide Retrospective Analysis in Japan
|
Itonaga, Hidehiro |
|
2018 |
24 |
4 |
p. 840-848 |
artikel |
30 |
Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance
|
Palazzo, Meighan |
|
2018 |
24 |
4 |
p. 871-876 |
artikel |
31 |
Risk Assessment in Adult T Cell Leukemia/Lymphoma Treated with Allogeneic Hematopoietic Stem Cell Transplantation
|
Yoshimitsu, Makoto |
|
2018 |
24 |
4 |
p. 832-839 |
artikel |
32 |
Risk Factors, Treatment, and Immune Dysregulation in Autoimmune Cytopenia after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients
|
Kruizinga, Matthijs D. |
|
2018 |
24 |
4 |
p. 772-778 |
artikel |
33 |
Risk of Exposure to Zika Virus and Impact on Cord Blood Banking and Adult Unrelated Donors in Hematopoietic Cell Transplantation: The Canadian Blood Services Experience
|
Adams, Zachary |
|
2018 |
24 |
4 |
p. 861-865 |
artikel |
34 |
Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables
|
Solomon, Scott R. |
|
2018 |
24 |
4 |
p. 789-798 |
artikel |
35 |
Stem Cell Transplantation and Informatics: Current Considerations
|
Jones, Roy B. |
|
2018 |
24 |
4 |
p. 659-665 |
artikel |
36 |
Table of Contents
|
|
|
2018 |
24 |
4 |
p. A11-A22 |
artikel |
37 |
Tandem Autologous Hematopoietic Cell Transplantation for Patients with Primary Progressive or Recurrent Hodgkin Lymphoma: A SWOG and Blood and Marrow Transplant Clinical Trials Network Phase II Trial (SWOG S0410/BMT CTN 0703)
|
Smith, Eileen P. |
|
2018 |
24 |
4 |
p. 700-707 |
artikel |
38 |
Transplant Decisions in Patients with Myelofibrosis: Should Mutations Be the Judge?
|
Salit, Rachel B. |
|
2018 |
24 |
4 |
p. 649-658 |
artikel |